A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia

• Status: Completed
• Trial end date: 2019-12-23
• Target enrollment: 0
• Participant gender: All

Summary

This study is to evaluate the safety and the efficacy of Prograf in patients with interstitial pneumonia associated with polymyositis / dermatomyositis in acute clinical setting.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Astellas Pharma Inc
• Treatments: Tacrolimus

Criteria

Inclusion Criteria:

• Hospitalized patient

• Patient diagnosed with Interstitial pneumonia associated with polymyositis/dermatomyositis